Leonard C Altman

Title: Leonard C. Altman: Innovator in Chemotactic Peptide Antibiotic Conjugates

Introduction

Leonard C. Altman is a notable inventor based in Seattle, WA. He has made significant contributions to the field of synthetic peptides and antibiotics. His innovative work focuses on developing effective treatments for infections, particularly through the use of chemotactic peptide-antibiotic conjugates.

Latest Patents

Leonard C. Altman holds a patent for "Formyl-methionyl chemotactic peptide antibiotic conjugates useful in treating infections." This patent describes a group of synthetic N-formyl methionine tri and tetra peptides that are covalently combined with antibiotics. These conjugates exhibit a high degree of chemotactic activity for polymorphonuclear leukocytes and monocytes while simultaneously inhibiting the growth of microorganisms. Notably, the use of chemotactic peptide-silver sulfadiazine conjugates has proven particularly effective for treating burns. He has 1 patent to his name.

Career Highlights

Leonard C. Altman is associated with Research, Incorporated, where he continues to advance his research in the field of peptide antibiotics. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from various infections.

Collaborations

Leonard has collaborated with Elliott Schiffman, contributing to the development of innovative solutions in the medical field. Their partnership has focused on enhancing the efficacy of antibiotic treatments through novel peptide conjugates.

Conclusion

Leonard C. Altman's contributions to the field of chemotactic peptide antibiotic conjugates highlight his innovative spirit and dedication to improving healthcare. His work continues to pave the way for new treatment options in the fight against infections.